Herbal Medicine: Open Access

We invite all the participants throughout the world to join us for the upcoming “25th International Congress on Pharmaceutical Biotechnology” on June 24-25, 2020 at Amsterdam, Netherlands. Euro Pharmaceutical Biotechnology 2020 is themed as “To explore the future of medicine in Pharmaceutical Biotechnology”.

For more conference details: Euro Pharmaceutical Biotechnology 2020

Market Analysis

Pharmaceutical Market Research Report:

Globally market biopharmaceuticals were worth $934.8 billion in 2017 and can reach $1170 billion in 2021, growing at 5.8%, in step with a recent pharmaceutical company research report. The pharmaceutical market in Asia is to upsurge from around $70 billion in 2016 to $72 billion by 2021, representing an occasional compound annual rate of growth of 0.3%, according to Global Data. The global biotechnology market is predicted to achieve USD 727.1 billion by 2025, in step with a brand-new report by Grand read analysis, Inc. Global Biotechnology Market will surpass USD 775 billion by 2024; according to new global market research by Global Market Insights, Inc. Innovations in biotechnology sector is predicted to upsurge revenue size throughout the forecast amount. Innovations such as developing human organs, growing plants in laboratory and meat coupled with rising demand for innovative biotechnological products will esteem business growth. Moreover, increasing stipulation for agriculture-based products should increase biotechnology industry growth over the coming years.

Research and Development:

During 2008-2015 period, the compound annual rate of worldwide R&D disbursement was 1.7% throughout the 2016-2022 period, the speed can grow at a pair of 0.8%.The year over year increase, however a stay around three dimensional, verses some dramatic jumps seen in 2013, 2014 and 2015. Overall disbursement can reach $182 billion in 2022. High speeders in 2015 were Roche & Novartis ($8.5 billion every in 2015), Pfizer ($7.7 billion), J&J ($6.8 billion), Merck ($6.6 billion), and Sanofi and AstraZeneca ($5.6 billion each).